
Photo credits: washingtonpost.com
Monoclonal antibodies — described as “unbelievable” by President Trump, who received the treatment this fall — are designed for patients newly diagnosed with covid-19, the disease caused by the coronavirus, who have a high risk of developing complications and becoming seriously ill.
Check the full article right here.